nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylscopolamine bromide—Tiotropium—CYP2D6—Parkinson's disease	0.0123	0.497	CrCbGaD
Methylscopolamine bromide—Ipratropium bromide—CYP2D6—Parkinson's disease	0.00644	0.261	CrCbGaD
Methylscopolamine bromide—Scopolamine—ABCB1—Parkinson's disease	0.00595	0.241	CrCbGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000771	0.00079	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—DRD1—Parkinson's disease	0.000771	0.00079	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000764	0.000783	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—GRM5—Parkinson's disease	0.000762	0.000781	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—GRM5—Parkinson's disease	0.000759	0.000778	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—DBH—Parkinson's disease	0.000756	0.000775	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—GBA—Parkinson's disease	0.000756	0.000775	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—FBP1—Parkinson's disease	0.000756	0.000775	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—GRM5—Parkinson's disease	0.000752	0.000771	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—DRD3—Parkinson's disease	0.000746	0.000765	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—GPR37—Parkinson's disease	0.000746	0.000764	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—DGKQ—Parkinson's disease	0.000746	0.000764	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—PDYN—Parkinson's disease	0.000744	0.000763	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—DGKQ—Parkinson's disease	0.000743	0.000762	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—GPR37—Parkinson's disease	0.000743	0.000762	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—PDYN—Parkinson's disease	0.000741	0.00076	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—GPR37—Parkinson's disease	0.000736	0.000755	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—DGKQ—Parkinson's disease	0.000736	0.000755	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—PDYN—Parkinson's disease	0.000734	0.000753	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—HTR1A—Parkinson's disease	0.000725	0.000743	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—GRM4—Parkinson's disease	0.00072	0.000738	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—TAC1—Parkinson's disease	0.000714	0.000732	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—DRD1—Parkinson's disease	0.0007	0.000717	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000697	0.000715	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—GRM5—Parkinson's disease	0.000692	0.000709	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—GRM5—Parkinson's disease	0.000689	0.000707	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—GRM5—Parkinson's disease	0.000683	0.0007	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PENK—Parkinson's disease	0.000682	0.0007	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MAG—Parkinson's disease	0.000682	0.0007	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000682	0.000699	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00068	0.000697	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—DRD3—Parkinson's disease	0.000678	0.000695	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—DRD2—Parkinson's disease	0.000675	0.000692	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—HTR7—Parkinson's disease	0.000675	0.000692	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—EDN1—Parkinson's disease	0.000673	0.00069	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000673	0.00069	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—EDN1—Parkinson's disease	0.000671	0.000688	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—EDN1—Parkinson's disease	0.000665	0.000681	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000647	0.000664	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000645	0.000662	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000639	0.000655	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000633	0.000649	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PDYN—Parkinson's disease	0.000624	0.00064	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—DRD2—Parkinson's disease	0.000613	0.000628	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—HTR7—Parkinson's disease	0.000613	0.000628	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Circadian rythm related genes—MAPK8—Parkinson's disease	0.000599	0.000614	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—RIT2—Parkinson's disease	0.000596	0.000611	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—RIT2—Parkinson's disease	0.000594	0.000609	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—HTR2A—Parkinson's disease	0.000589	0.000604	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—RIT2—Parkinson's disease	0.000588	0.000603	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000588	0.000603	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—HTR2A—Parkinson's disease	0.000587	0.000602	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—GFAP—Parkinson's disease	0.000587	0.000602	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000586	0.000601	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—HTR2A—Parkinson's disease	0.000581	0.000596	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—ADORA2A—Parkinson's disease	0.00058	0.000595	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—GRM5—Parkinson's disease	0.00058	0.000595	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000573	0.000588	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—GRK5—Parkinson's disease	0.000565	0.000579	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—GRK5—Parkinson's disease	0.000563	0.000577	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000562	0.000576	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00056	0.000574	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—GRK5—Parkinson's disease	0.000558	0.000572	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—DDC—Parkinson's disease	0.000555	0.000569	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000555	0.000569	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—TAC1—Parkinson's disease	0.000553	0.000567	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—TAC1—Parkinson's disease	0.000552	0.000565	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—TAC1—Parkinson's disease	0.000546	0.00056	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—DRD1—Parkinson's disease	0.000543	0.000556	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—DRD1—Parkinson's disease	0.000541	0.000555	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—EDN1—Parkinson's disease	0.00054	0.000554	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—DRD1—Parkinson's disease	0.000536	0.000549	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—DRD3—Parkinson's disease	0.000526	0.000539	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—DRD3—Parkinson's disease	0.000524	0.000537	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—GSTA4—Parkinson's disease	0.000524	0.000537	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—DRD3—Parkinson's disease	0.000519	0.000532	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000515	0.000528	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—HTR1A—Parkinson's disease	0.00051	0.000523	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—FGF20—Parkinson's disease	0.000509	0.000522	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—HTR1A—Parkinson's disease	0.000509	0.000521	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—GRM4—Parkinson's disease	0.000507	0.00052	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—GRM4—Parkinson's disease	0.000505	0.000518	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—HTR1A—Parkinson's disease	0.000504	0.000516	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—TAC1—Parkinson's disease	0.000502	0.000515	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—TAC1—Parkinson's disease	0.000501	0.000514	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—GRM4—Parkinson's disease	0.0005	0.000513	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—TAC1—Parkinson's disease	0.000496	0.000509	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—ADORA2A—Parkinson's disease	0.000493	0.000506	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—DRD1—Parkinson's disease	0.000493	0.000505	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—DRD1—Parkinson's disease	0.000491	0.000504	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—EDN1—Parkinson's disease	0.000491	0.000503	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000491	0.000503	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000489	0.000502	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—DRD1—Parkinson's disease	0.000486	0.000499	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000484	0.000497	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PENK—Parkinson's disease	0.00048	0.000493	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MAG—Parkinson's disease	0.00048	0.000493	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MAG—Parkinson's disease	0.000479	0.000491	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PENK—Parkinson's disease	0.000479	0.000491	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—DRD3—Parkinson's disease	0.000477	0.000489	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—DRD3—Parkinson's disease	0.000476	0.000488	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—HTR7—Parkinson's disease	0.000475	0.000487	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—DRD2—Parkinson's disease	0.000475	0.000487	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PENK—Parkinson's disease	0.000474	0.000486	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MAG—Parkinson's disease	0.000474	0.000486	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—DRD2—Parkinson's disease	0.000474	0.000486	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—HTR7—Parkinson's disease	0.000474	0.000486	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000473	0.000485	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PLA2G6—Parkinson's disease	0.000472	0.000484	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—DRD3—Parkinson's disease	0.000471	0.000483	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—DRD2—Parkinson's disease	0.000469	0.000481	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—HTR7—Parkinson's disease	0.000469	0.000481	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—MAOB—Parkinson's disease	0.000467	0.000479	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000463	0.000474	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—INSR—Parkinson's disease	0.000455	0.000467	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000446	0.000457	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000444	0.000455	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—ADRBK1—Parkinson's disease	0.00044	0.000451	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PDYN—Parkinson's disease	0.000439	0.000451	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PDYN—Parkinson's disease	0.000438	0.000449	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PDYN—Parkinson's disease	0.000434	0.000445	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—DRD2—Parkinson's disease	0.000432	0.000442	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—HTR7—Parkinson's disease	0.000432	0.000442	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—FGB—Parkinson's disease	0.00043	0.000441	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—HTR7—Parkinson's disease	0.00043	0.000441	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—DRD2—Parkinson's disease	0.00043	0.000441	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—HTR2A—Parkinson's disease	0.000429	0.00044	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—HTR1A—Parkinson's disease	0.000428	0.000439	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—DRD2—Parkinson's disease	0.000426	0.000437	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—HTR7—Parkinson's disease	0.000426	0.000437	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—TAC1—Parkinson's disease	0.000422	0.000432	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—DRD1—Parkinson's disease	0.000413	0.000424	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—GFAP—Parkinson's disease	0.000413	0.000424	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—GFAP—Parkinson's disease	0.000412	0.000422	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—GRM5—Parkinson's disease	0.000409	0.000419	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—GFAP—Parkinson's disease	0.000408	0.000418	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—GRM5—Parkinson's disease	0.000407	0.000417	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—GRM5—Parkinson's disease	0.000403	0.000413	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—DRD3—Parkinson's disease	0.0004	0.00041	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Circadian rythm related genes—IL6—Parkinson's disease	0.000383	0.000392	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—EDN1—Parkinson's disease	0.00038	0.00039	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—EDN1—Parkinson's disease	0.000379	0.000389	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—EDN1—Parkinson's disease	0.000376	0.000385	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—ADRBK1—Parkinson's disease	0.000374	0.000383	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000362	0.000372	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—HTR7—Parkinson's disease	0.000362	0.000371	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—DRD2—Parkinson's disease	0.000362	0.000371	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000361	0.00037	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—FGF20—Parkinson's disease	0.000358	0.000367	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—FGF20—Parkinson's disease	0.000357	0.000366	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—FGF20—Parkinson's disease	0.000354	0.000363	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000347	0.000356	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—CYP2D6—Parkinson's disease	0.000347	0.000356	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—ADORA2A—Parkinson's disease	0.000346	0.000355	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—EDN1—Parkinson's disease	0.000346	0.000354	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—EDN1—Parkinson's disease	0.000344	0.000353	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—ADORA2A—Parkinson's disease	0.000343	0.000352	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—EDN1—Parkinson's disease	0.000341	0.00035	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—CTGF—Parkinson's disease	0.000341	0.000349	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000333	0.000341	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000332	0.00034	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000329	0.000337	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—INSR—Parkinson's disease	0.000321	0.000329	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—INSR—Parkinson's disease	0.00032	0.000328	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—CYP2E1—Parkinson's disease	0.000317	0.000325	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—INSR—Parkinson's disease	0.000316	0.000324	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—NQO1—Parkinson's disease	0.000314	0.000322	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—TH—Parkinson's disease	0.000309	0.000317	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IGF2—Parkinson's disease	0.000303	0.000311	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—FGB—Parkinson's disease	0.000303	0.000311	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—HTR2A—Parkinson's disease	0.000302	0.00031	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—FGB—Parkinson's disease	0.000302	0.00031	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—HTR1A—Parkinson's disease	0.000301	0.000309	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—HTR2A—Parkinson's disease	0.000301	0.000309	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—HTR1A—Parkinson's disease	0.0003	0.000308	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—FGB—Parkinson's disease	0.000299	0.000307	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—HTR2A—Parkinson's disease	0.000298	0.000306	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—HTR1A—Parkinson's disease	0.000298	0.000305	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—CYCS—Parkinson's disease	0.000297	0.000304	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TAC1—Parkinson's disease	0.000297	0.000304	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TAC1—Parkinson's disease	0.000296	0.000303	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IGF1R—Parkinson's disease	0.000293	0.000301	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TAC1—Parkinson's disease	0.000293	0.0003	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—DRD1—Parkinson's disease	0.000291	0.000298	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—DRD1—Parkinson's disease	0.00029	0.000297	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—EDN1—Parkinson's disease	0.00029	0.000297	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—DRD1—Parkinson's disease	0.000287	0.000295	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—DRD3—Parkinson's disease	0.000282	0.000289	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—DRD3—Parkinson's disease	0.000281	0.000288	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—DRD3—Parkinson's disease	0.000278	0.000285	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—NGF—Parkinson's disease	0.000266	0.000273	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—ADRBK1—Parkinson's disease	0.000263	0.00027	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—COMT—Parkinson's disease	0.000263	0.00027	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—ADRBK1—Parkinson's disease	0.000262	0.000269	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—GSTP1—Parkinson's disease	0.000262	0.000268	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—MAOA—Parkinson's disease	0.000261	0.000268	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—ADRBK1—Parkinson's disease	0.00026	0.000266	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—HMOX1—Parkinson's disease	0.000258	0.000265	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—DRD2—Parkinson's disease	0.000255	0.000261	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—HTR7—Parkinson's disease	0.000255	0.000261	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—DRD2—Parkinson's disease	0.000254	0.000261	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—HTR7—Parkinson's disease	0.000254	0.000261	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—HTR2A—Parkinson's disease	0.000254	0.00026	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—HTR7—Parkinson's disease	0.000252	0.000258	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—DRD2—Parkinson's disease	0.000252	0.000258	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—ABCB1—Parkinson's disease	0.000248	0.000254	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—GSTM1—Parkinson's disease	0.000241	0.000247	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—APOE—Parkinson's disease	0.000236	0.000242	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—GPX1—Parkinson's disease	0.00023	0.000236	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IGF2—Parkinson's disease	0.000214	0.000219	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IGF2—Parkinson's disease	0.000213	0.000218	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—MTHFR—Parkinson's disease	0.000213	0.000218	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IGF2—Parkinson's disease	0.000211	0.000216	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IGF1R—Parkinson's disease	0.000207	0.000212	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IGF1R—Parkinson's disease	0.000206	0.000211	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—EDN1—Parkinson's disease	0.000204	0.000209	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IGF1R—Parkinson's disease	0.000204	0.000209	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—EDN1—Parkinson's disease	0.000203	0.000209	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—EDN1—Parkinson's disease	0.000201	0.000207	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—INS—Parkinson's disease	0.000201	0.000206	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—APOE—Parkinson's disease	0.000198	0.000203	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NGF—Parkinson's disease	0.000188	0.000192	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NGF—Parkinson's disease	0.000187	0.000192	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NGF—Parkinson's disease	0.000185	0.00019	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—HTR2A—Parkinson's disease	0.000179	0.000183	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—HTR2A—Parkinson's disease	0.000178	0.000182	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—HTR2A—Parkinson's disease	0.000176	0.000181	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—INS—Parkinson's disease	0.000169	0.000173	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—APOE—Parkinson's disease	0.000166	0.00017	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—APOE—Parkinson's disease	0.000165	0.00017	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—APOE—Parkinson's disease	0.000164	0.000168	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CASP3—Parkinson's disease	0.00015	0.000154	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—IL6—Parkinson's disease	0.000149	0.000153	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—INS—Parkinson's disease	0.000142	0.000145	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—INS—Parkinson's disease	0.000141	0.000145	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—INS—Parkinson's disease	0.00014	0.000144	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MAPK8—Parkinson's disease	0.000138	0.000141	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CASP3—Parkinson's disease	0.000106	0.000108	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CASP3—Parkinson's disease	0.000105	0.000108	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—IL6—Parkinson's disease	0.000105	0.000108	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—IL6—Parkinson's disease	0.000105	0.000107	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CASP3—Parkinson's disease	0.000104	0.000107	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—IL6—Parkinson's disease	0.000104	0.000106	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MAPK8—Parkinson's disease	9.7e-05	9.95e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MAPK8—Parkinson's disease	9.67e-05	9.92e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MAPK8—Parkinson's disease	9.58e-05	9.82e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IL6—Parkinson's disease	8.8e-05	9.02e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IL6—Parkinson's disease	6.2e-05	6.35e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IL6—Parkinson's disease	6.18e-05	6.33e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IL6—Parkinson's disease	6.12e-05	6.27e-05	CbGpPWpGaD
